Basic Information
Everlife Asia is a buy-and-build platform designed to provide comprehensive solutions for the healthcare and research industries in Southeast Asia and India. As part of the Everstone Group, Everlife invests in manufacturers and distributors in the region, covering key strategic areas including in vitro diagnostics, medical diagnostics, critical care equipment, implants, and consumables. Cure Capital is a minority shareholder in Everlife. Everlife's portfolio companies represent over 200 principals and employ more than 600 staff operating across seven countries.